Greatbatch To Boost Cardiac And Neurostim Presence With Enpath Purchase
This article was originally published in The Gray Sheet
Executive Summary
Greatbatch hopes to expand its reach in the cardiac rhythm management and neurostimulation markets with a $102 million acquisition of Enpath announced April 30